DA32 Life Science Tech Acquisition Corp.
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company..
Debt to Assets
| Q1 2021 | 95000 | 71.51K | 75.28% |
|---|---|---|---|
| Q3 2021 | 202680392 | 5.81M | 2.87% |
| Q2 2021 | 202819055 | 5.72M | 2.82% |
| Q4 2021 | 2468243 | 5.88M | 238.49% |
DALS Balance Sheet (Q1 2021 – Q4 2021)
| Q4 2021 | Q2 2021 | Q3 2021 | Q1 2021 | |
|---|---|---|---|---|
Assets | ||||
Current assets: | ||||
Cash and cash equivalents | 1.86M | 1.26M | 1.95M | 25K |
Short term investments | 0 | 0 | 0 | 0 |
Net receivables | 0 | 800K | 0 | 0 |
Inventory | 0 | 0 | 0 | 0 |
Other current assets | 603.32K | 0 | 0 | 0 |
Total current assets | 2.46M | 2.81M | 2.67M | 25K |
Non-current assets: | ||||
Property, Plant and Equipment | 0 | 0 | 0 | 0 |
Goodwill | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 |
Long term investments | 0 | 0 | 0 | 0 |
Other non-current assets | 0 | 200M | 200.00M | 0 |
Total non-current assets | 0 | 200M | 200.00M | 70K |
Total assets | 2.46M | 202.81M | 202.68M | 95K |
Liabilities | ||||
| Current liabilities: | ||||
Accounts payable | ||||
Deferred revenue | 0 | 0 | 0 | 0 |
Short term debt | 0 | 200K | 0 | 0 |
Total current liabilities | 286.51K | 128.55K | 216.82K | 71.51K |
| Non-current liabilities: | ||||
Long term debt | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 |
Other non-current liabilities | 5.6M | 0 | 0 | 0 |
Total non-current liabilities | 5.6M | 5.6M | 5.6M | 0 |
Total liabilities | 5.88M | 5.72M | 5.81M | 71.51K |
| Data source | Data source | Data source |